Literature DB >> 12244198

Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways.

Philipp Henneke1, Osamu Takeuchi, Richard Malley, Egil Lien, Robin R Ingalls, Mason W Freeman, Tanya Mayadas, Victor Nizet, Shizuo Akira, Dennis L Kasper, Douglas T Golenbock.   

Abstract

Group B streptococci (GBS) vigorously activate inflammatory responses. We reported previously that a secreted GBS "factor" activates phagocytes via Toll-like receptor (TLR)2 and TLR6, but that GBS cell walls activate cells independently of these receptors. We hypothesized that the phagocytic immune functions in response to GBS, such as inflammation, uptake, and elimination of bacteria, occur through a coordinated engagement of TLRs, along with the coreceptors CD14 and CD11b/CD18. Using various knockout mice we show that GBS-induced activation of p38 and NF-kappaB depends upon the expression of the cytoplasmic TLR adapter protein, myeloid differentiation factor 88 (MyD88), but not TLR2 and/or TLR4. Macrophages with deletions of CD14 and complement receptor 3 had a normal cytokine response to whole bacteria, although the response to GBS factor was abrogated in CD14-null cells. The intracellular formation of bactericidal oxygen species proved to be MyD88 dependent; however, uptake of GBS, a prerequisite for intracellular killing by O(2) radicals, occurred independently of MyD88. While deletion of complement receptor 3 greatly diminished the uptake of opsonized GBS, it did not affect the formation of bactericidal O(2) radicals or inflammatory signaling intermediates. We conclude that the inflammatory, bactericidal, and phagocytic responses to GBS occur via parallel but independent processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244198     DOI: 10.4049/jimmunol.169.7.3970

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis.

Authors:  Laura E Fredenburgh; Margarita M Suárez Velandia; Jun Ma; Torsten Olszak; Manuela Cernadas; Joshua A Englert; Su Wol Chung; Xiaoli Liu; Cynthia Begay; Robert F Padera; Richard S Blumberg; Stephen R Walsh; Rebecca M Baron; Mark A Perrella
Journal:  J Immunol       Date:  2011-10-03       Impact factor: 5.422

2.  Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia.

Authors:  Tammy Kielian; Nilufer Esen; Edward D Bearden
Journal:  Glia       Date:  2005-03       Impact factor: 7.452

Review 3.  The role of Toll-like receptors in CNS response to microbial challenge.

Authors:  Gregory W Konat; Tammy Kielian; Ian Marriott
Journal:  J Neurochem       Date:  2006-08-08       Impact factor: 5.372

Review 4.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 5.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

Review 6.  Recent advances in understanding the molecular basis of group B Streptococcus virulence.

Authors:  Heather C Maisey; Kelly S Doran; Victor Nizet
Journal:  Expert Rev Mol Med       Date:  2008-09-22       Impact factor: 5.600

7.  Toll-like receptor 2 deficiency delays pneumococcal phagocytosis and impairs oxidative killing by granulocytes.

Authors:  Maryse Letiembre; Hakim Echchannaoui; Philipp Bachmann; Fabrizia Ferracin; Concepción Nieto; Manuel Espinosa; Regine Landmann
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  Toll-like receptor 2 deficiency is associated with enhanced severity of group B streptococcal disease.

Authors:  Manuela Puliti; Satoshi Uematsu; Shizuo Akira; Francesco Bistoni; Luciana Tissi
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

9.  Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens.

Authors:  Kieren A Marr; S Arunmozhi Balajee; Thomas R Hawn; Adrian Ozinsky; Uyenvy Pham; Shizuo Akira; Alan Aderem; W Conrad Liles
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  Lipoteichoic acid is important in innate immune responses to gram-positive bacteria.

Authors:  Ho Seong Seo; Suzanne M Michalek; Moon H Nahm
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.